← Eichor
Study identifier: NCT05633706 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

Condition: Irritable Bowel Syndrome · Crohn Disease · Celiac Disease  ·  Sponsor: Nimble Science Ltd.

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersYes

About this study

The SIMBA Capsule is a small, single-use, ingestible capsule that allows for the non-invasive sampling of small bowel contents using purely mechanical means. The study will compare the microbial and metabolomics analysis from the sample collected with the capsule series, to same-participant symptom questionnaires and stool microbial analysis.

This description comes directly from the study's public registry record.

Talk to the study team

Gwen Duytschaever, PhD  ·  8664934633  ·  clinical@nimblesci.com

Always discuss trial participation with your own doctor first.

Locations (1)

Nimble ScienceCalgary, Alberta, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05633706